Concepedia
Statistics
Publications
7
Citations
424
H-Index
Active since
1998
Affiliations
Novartis (Switzerland)(Current)
Tris Pharma (United States)
Zhengming Du is an author at Novartis (Switzerland) specializing in pharmacology, chemistry, and engineering.
Top concepts
PharmacologyMedicineChemistryEngineeringDrug DiscoveryCatalysisNatural SciencesOrganic ChemistryMedicinal ChemistryBiomolecular Engineering
Publications per year
1998–2014
Identification of Dipeptidyl Nitriles as Potent and Selective Inhibitors of Cathepsin B through Structure-Based Drug Design
Paul D. Greenspan, Kirk Clark, Rubén Tommasi et al. · Journal of Medicinal Chemistry · 2001 · 136 citations · Full text
Preclinical pharmacology of lumiracoxib: a novel selective inhibitor of cyclooxygenase‐2
Ronald E. Esser, Carol Berry, Zhengming Du et al. · British Journal of Pharmacology · 2005 · 123 citations · Full text
Immunology, Cellular Pharmacology, Pharmacotherapy +17
Optimization of Halopemide for Phospholipase D2 inhibition
Lauren G. Monovich, Benjamin Mugrage, Elizabeth Quadros et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 99 citations · Full text
Medicinal Chemistry, Medicine, Mechanism Of Action +4
A Scalable Zinc Activation Procedure Using DIBAL-H in a Reformatsky Reaction
Michael Girgis, Jessica K. Liang, Zhengming Du et al. · Organic Process Research & Development · 2009 · 23 citations
Inorganic Chemistry, Chemical Engineering, Engineering +10
Practical Asymmetric Hydrogenation-Based Synthesis of a Class-Selective Histone Deacetylase Inhibitor
Junli Chen, Tianqi Chen, Qiupeng Hu et al. · Organic Process Research & Development · 2014 · 17 citations
Bioorganic Chemistry, Engineering, Molecular Biology +17
1–5 of 7